Healthcare -
Biotechnology - NASDAQ - US
$ 7.675
-2.23 %
$ 407 M
Market Cap
-3.69
P/E
Price Target
Average
202.28%
Revenue Forecast
Estimate
134.96%
EBIT
Estimate
30.03%
Net Income
Estimate
10.78%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Stoke Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for STOK of $23.2 , with forecasts ranging from
a
low of
$18 to a high of $35 .
STOK Lowest Price Target
Wall Street Target
18 USD
134.53%
STOK Average Price Target
Wall Street Target
23.2 USD
202.28%
STOK Highest Price Target
Wall Street Target
35 USD
356.03%
REVENUE FORECAST
Revenue Forecast Chart STOK
EBIT FORECAST
EBIT Forecast Chart STOK
NET INCOME FORECAST
Net Income Chart STOK